Are fatty nuts a weighty concern? A systematic review and meta-analysis and dose-response meta-regression of prospective cohorts and randomized controlled trials

Stephanie K Nishi, Effie Viguiliouk, Sonia Blanco Mejia, Cyril W C Kendall, Richard P Bazinet, Anthony J Hanley, Elena M Comelli, Jordi Salas Salvadó, David J A Jenkins, John L Sievenpiper, Stephanie K Nishi, Effie Viguiliouk, Sonia Blanco Mejia, Cyril W C Kendall, Richard P Bazinet, Anthony J Hanley, Elena M Comelli, Jordi Salas Salvadó, David J A Jenkins, John L Sievenpiper

Abstract

Nuts are recommended for cardiovascular health, yet concerns remain that nuts may contribute to weight gain due to their high energy density. A systematic review and meta-analysis of prospective cohorts and randomized controlled trials (RCTs) was conducted to update the evidence, provide a dose-response analysis, and assess differences in nut type, comparator and more in subgroup analyses. MEDLINE, EMBASE, and Cochrane were searched, along with manual searches. Data from eligible studies were pooled using meta-analysis methods. Interstudy heterogeneity was assessed (Cochran Q statistic) and quantified (I2 statistic). Certainty of the evidence was assessed by Grading of Recommendations Assessment, Development, and Evaluation (GRADE). Six prospective cohort studies (7 unique cohorts, n = 569,910) and 86 RCTs (114 comparisons, n = 5873) met eligibility criteria. Nuts were associated with lower incidence of overweight/obesity (RR 0.93 [95% CI 0.88 to 0.98] P < 0.001, "moderate" certainty of evidence) in prospective cohorts. RCTs presented no adverse effect of nuts on body weight (MD 0.09 kg, [95% CI -0.09 to 0.27 kg] P < 0.001, "high" certainty of evidence). Meta-regression showed that higher nut intake was associated with reductions in body weight and body fat. Current evidence demonstrates the concern that nut consumption contributes to increased adiposity appears unwarranted.

Trial registration: ClinicalTrials.gov NCT02654535.

Keywords: body weight; meta-analysis; nuts; systematic review.

Conflict of interest statement

SKN serves as a volunteer member of the not‐for‐profit group Plant‐Based Canada as of 2019. EV served as a scientific advisor for New Era Nutrition from 2019 to 2020. SBM reports no competing interests. CWCK has received research support from the Advanced Foods and Materials Network, Agricultural Bioproducts Innovation Program through the Pulse Research Network, Agriculture and Agri‐Food Canada, Almond Board of California, Barilla, Calorie Control Council, CIHR, Canola Council of Canada, The International Tree Nut Council Nutrition Research & Education Foundation, Kellogg, Loblaw Companies Ltd., Pulse Canada, Saskatchewan Pulse Growers, and Unilever. He has received consultant fees from American Pistachio Growers, speaker fees from the Peanut Institute, Tate & Lyle and The WhiteWave Foods Company, and travel funding from Sabra Dipping Company, Tate & Lyle, International Tree Nut Council Research & Education Foundation, California Walnut Commission, Sun‐Maid, The Peanut Institute, General Mills, Oldways Foundation, and International Nut and Dried Fruit Council Foundation. He is on the Clinical Practice Guidelines Expert Committee for Nutrition Therapy of the European Association for the Study of Diabetes (EASD). He is a member of the International Carbohydrate Quality Consortium (ICQC), Secretary of the Diabetes and Nutrition Study Group (DNSG) of the EASD, and a Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation. RPB has received research grants from Bunge Ltd., Arctic Nutrition, the Dairy Farmers of Canada, and Nestle Inc., as well as travel support from Mead Johnson and mass spectrometry equipment and support from Sciex. RPB is on the executive of the International Society for the Study of Fatty acids and Lipids and held a meeting on behalf of Fatty Acids and Cell Signaling, both of which rely on corporate sponsorship. AJH has received research support from the Dairy Farmers of Canada. JSS received financial support by ICREA under the ICREA Academia program; the SEMERGEN grant; Department of Health of the Government of Navarra (61/2015); the Fundació La Marató de TV (Ref. 201630.10); the AstraZeneca Young Investigators Award in Category of Obesity and T2D 2017 (D.R.); grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013; PS0358/2016; PI0137/2018); the PROMETEO/2017/017 grant from the Generalitat Valenciana, and the SEMERGEN grant; and grant of support to research groups 35/2011 (Balearic Islands Government; FEDER funds) (J.A.T.). EMC has received grants and/or research support from Dairy Farmers of Canada, Lallemand Health Solutions, and Ocean Spray and has received consultant fees or speaker or travel support from Danone, Nestlé, and Lallemand Health Solutions. DJAJ has received research grants from Saskatchewan & Alberta Pulse Growers Associations; the Agricultural Bioproducts Innovation Program through the Pulse Research Network; the Advanced Foods and Material Network; Loblaw Companies Ltd.; Unilever Canada and Netherlands; Barilla; the Almond Board of California; Agriculture and Agri‐food Canada; Pulse Canada; Kellogg's Company, Canada; Quaker Oats, Canada; Procter & Gamble Technical Centre Ltd.; Bayer Consumer Care, Springfield, NJ; Pepsi/Quaker; International Nut & Dried Fruit Council (INC); Soy Foods Association of North America; the Coca‐Cola Company (investigator initiated, unrestricted grant); Solae; Haine Celestial; the Sanitarium Company; Orafti; the International Tree Nut Council Nutrition Research and Education Foundation; the Peanut Institute; Soy Nutrition Institute (SNI); the Canola and Flax Councils of Canada; the Calorie Control Council; the Canadian Institutes of Health Research (CIHR); the Canada Foundation for Innovation (CFI); and the Ontario Research Fund (ORF). He has received in‐kind supplies for trials as a research support from the Almond board of California, Walnut Council of California, the Peanut Institute, Barilla, Unilever, Unico, Primo, Loblaw Companies, Quaker (Pepsico), Pristine Gourmet, Bunge Limited, Kellogg Canada, and WhiteWave Foods. He has been on the speaker's panel, served on the scientific advisory board, and/or received travel support and/or honoraria from 2020 China Glycemic Index (GI) International Conference, Atlantic Pain Conference, Academy of Life Long Learning, the Almond Board of California, Canadian Agriculture Policy Institute, Loblaw Companies Ltd, the Griffin Hospital (for the development of the NuVal scoring system), the Coca‐Cola Company, Epicure, Danone, Diet Quality Photo Navigation (DQPN), Better Therapeutics (FareWell), Verywell, True Health Initiative (THI), Heali AI Corp, Institute of Food Technologists (IFT), Soy Nutrition Institute (SNI), Herbalife Nutrition Institute (HNI), Saskatchewan & Alberta Pulse Growers Associations, Sanitarium Company, Orafti, the International Tree Nut Council Nutrition Research and Education Foundation, the Peanut Institute, Herbalife International, Pacific Health Laboratories, Nutritional Fundamentals for Health (NFH), Barilla, Metagenics, Bayer Consumer Care, Unilever Canada and Netherlands, Solae, Kellogg, Quaker Oats, Procter & Gamble, Abbott Laboratories, Dean Foods, the California Strawberry Commission, Haine Celestial, PepsiCo, the Alpro Foundation, Pioneer Hi‐Bred International, DuPont Nutrition and Health, Spherix Consulting and WhiteWave Foods, the Advanced Foods and Material Network, the Canola and Flax Councils of Canada, Agri‐Culture and Agri‐Food Canada, the Canadian Agri‐Food Policy Institute, Pulse Canada, the Soy Foods Association of North America, the Nutrition Foundation of Italy (NFI), Nutra‐Source Diagnostics, the McDougall Program, the Toronto Knowledge Translation Group (St. Michael's Hospital), the Canadian College of Naturopathic Medicine, The Hospital for Sick Children, the Canadian Nutrition Society (CNS), the American Society of Nutrition (ASN), Arizona State University, Paolo Sorbini Foundation and the Institute of Nutrition, and Metabolism and Diabetes. He received an honorarium from the United States Department of Agriculture to present the 2013 W.O. Atwater Memorial Lecture. He received the 2013 Award for Excellence in Research from the International Nut and Dried Fruit Council. He received funding and travel support from the Canadian Society of Endocrinology and Metabolism to produce mini cases for the Canadian Diabetes Association (CDA). He is a member of the International Carbohydrate Quality Consortium (ICQC). His wife, Alexandra L Jenkins, is a director and partner of INQUIS Clinical Research for the Food Industry, his two daughters, Wendy Jenkins and Amy Jenkins, have published a vegetarian book that promotes the use of the foods described here, The Portfolio Diet for Cardiovascular Risk Reduction (Academic Press/Elsevier 2020 ISBN:978‐0‐12‐810510‐8) and his sister, Caroline Brydson, received funding through a grant from the St. Michael's Hospital Foundation to develop a cookbook for one of his studies. JLS has received research support from the Canadian Foundation for Innovation, Ontario Research Fund, Province of Ontario Ministry of Research and Innovation and Science, Canadian Institutes of health Research (CIHR), Diabetes Canada, PSI Foundation, Banting and Best Diabetes Centre (BBDC), American Society for Nutrition (ASN), INC International Nut and Dried Fruit Council Foundation, National Dried Fruit Trade Association, National Honey Board (the U.S. Department of Agriculture [USDA] honey “Checkoff” program), International Life Sciences Institute (ILSI), Pulse Canada, Quaker Oats Center of Excellence, The United Soybean Board (the USDA soy “Checkoff” program), The Tate and Lyle Nutritional Research Fund at the University of Toronto, The Glycemic Control and Cardiovascular Disease in Type 2 Diabetes Fund at the University of Toronto (a fund established by the Alberta Pulse Growers), and The Nutrition Trialists Fund at the University of Toronto (a fund established by an inaugural donation from the Calorie Control Council). He has received in‐kind food donations to support a randomized controlled trial from the Almond Board of California, California Walnut Commission, Peanut Institute, Barilla, Unilever/Upfield, Unico/Primo, Loblaw Companies, Quaker, Kellogg Canada, WhiteWave Foods/Danone, and Nutrartis. He has received travel support, speaker fees, and/or honoraria from Diabetes Canada, Dairy Farmers of Canada, FoodMinds LLC, International Sweeteners Association, Nestlé, Pulse Canada, Canadian Society for Endocrinology and Metabolism (CSEM), GI Foundation, Abbott, General Mills, Biofortis, ASN, Northern Ontario School of Medicine, INC Nutrition Research & Education Foundation, European Food Safety Authority (EFSA), Comité Européen des Fabricants de Sucre (CEFS), Nutrition Communications, International Food Information Council (IFIC), Calorie Control Council, International Glutamate Technical Committee, and Physicians Committee for Responsible Medicine. He has or has had ad hoc consulting arrangements with Perkins Coie LLP, Tate & Lyle, Wirtschaftliche Vereinigung Zucker e.V., Danone, and Inquis Clinical Research. He is a member of the European Fruit Juice Association Scientific Expert Panel and former member of the Soy Nutrition Institute (SNI) Scientific Advisory Committee. He is on the Clinical Practice Guidelines Expert Committees of Diabetes Canada, European Association for the study of Diabetes (EASD), Canadian Cardiovascular Society (CCS), and Obesity Canada/Canadian Association of Bariatric Physicians and Surgeons. He serves or has served as an unpaid scientific advisor for the Food, Nutrition, and Safety Program (FNSP) and the Technical Committee on Carbohydrates of ILSI North America. He is a member of the International Carbohydrate Quality Consortium (ICQC), Executive Board Member of the Diabetes and Nutrition Study Group (DNSG) of the EASD and Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation. His wife is an employee of AB InBev. There are no patents, products in development, or marketed products to declare.

© 2021 The Authors. Obesity Reviews published by John Wiley & Sons Ltd on behalf of World Obesity Federation.

Figures

FIGURE 1
FIGURE 1
Summary of evidence search and selection
FIGURE 2
FIGURE 2
(A) Summary of the pooled effect estimates of prospective cohort studies assessing the association between tree nut and peanut intake and adiposity incidence outcomes, with GRADE assessment. (B) Summary of the pooled effect estimates of prospective cohort studies assessing the association between tree nut and peanut intake and body weight change outcome, with Grading of Recommendations Assessment, Development, and Evaluation (GRADE) assessment
FIGURE 3
FIGURE 3
Summary of the pooled effect estimates of randomized controlled trials assessing the association between tree nut and peanut intake and adiposity outcomes, with Grading of Recommendations Assessment, Development, and Evaluation (GRADE) assessment

References

    1. Pasquarelli‐do‐Nascimento G, Braz‐de‐Melo HA, Faria SS, Santos IDO, Kobinger GP, Magalhães KG. Hypercoagulopathy and adipose tissue exacerbated inflammation may explain higher mortality in COVID‐19 patients with obesity. Front Endocrinol. 2020;11:530.
    1. Viguiliouk E, Kendall CW, Blanco Mejia S, et al. Effect of tree nuts on glycemic control in diabetes: A systematic review and meta‐analysis of randomized controlled dietary trials. PLoS ONE. 2014;9(7):e103376.
    1. Blanco Mejia S, Kendall CW, Viguiliouk E, et al. Effect of tree nuts on metabolic syndrome criteria: A systematic review and meta‐analysis of randomised controlled trials. BMJ Open. 2014;4(7):e004660.
    1. Lee‐Bravatti MA, Wang J, Avendano EE, King L, Johnson EJ, Raman G. Almond consumption and risk factors for cardiovascular disease: A systematic review and meta‐analysis of randomized controlled trials. Adv Nutr (Bethesda, Md). 2019;10:1076‐1088.
    1. Becerra‐Tomas N, Paz‐Graniel I, Kendall CWC, et al. Nut consumption and incidence of cardiovascular diseases and cardiovascular disease mortality: A meta‐analysis of prospective cohort studies. Nutr Rev. 2019;77(10):691‐709.
    1. U.S. Department of Health and Human Services and U.S. Department of Agriculture . 2015–2020 Dietary Guidelines for Americans. 8th Edition. December 2015. Available at
    1. Health Canada , Government of Canada . Canada's Dietary Guidelines for Health Professionals and Policy Makers. Last Modified: 22 January 2019. Available:
    1. European Commission . Food‐Based Dietary Guidelines in Europe. Last Modified: 01/02/2020. Available:
    1. Binns CW, Lee MK, Kagawa M, et al. Dietary guidelines for the Asia Pacific region. Asia Pac J Public Health. 2017;29(2):98‐101.
    1. Herforth A, Arimond M, Alvarez‐Sanchez C, Coates J, Christianson K, Muehlhoff E. A global review of food‐based dietary guidelines. Adv Nutr (Bethesda, Md). 2019;10:590‐605.
    1. Chiavaroli L, Nishi SK, Khan TA, et al. Portfolio dietary pattern and cardiovascular disease: A systematic review and meta‐analysis of controlled trials. Prog Cardiovasc Dis. 2018;61(1):43‐53.
    1. Chiavaroli L, Viguiliouk E, Nishi SK, et al. DASH dietary pattern and cardiometabolic outcomes: An umbrella review of systematic reviews and meta‐analyses. Nutrients. 2019;11(2):338.
    1. Sievenpiper JL, Chan CB, Dworatzek PD, Freeze C, Williams SL. Nutrition therapy. Can J Diabetes. 2018;42(Suppl 1):S64‐s79.
    1. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25):2960‐2984.
    1. Anderson TJ, Gregoire J, Pearson GJ, et al. 2016 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2016;32(11):1263‐1282.
    1. Mann JI, De Leeuw I, Hermansen K, et al. Evidence‐based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr Metab Cardiovasc Dis: NMCD. 2004;14(6):373‐394.
    1. U.S. Food and Drug Administration (FDA) . Guidance for Industry: A Food Labeling Guide (12. Appendix D: Qualified Health Claims). Qualified Health Claims: Letter of Enforcement Discretion ‐ Nuts and Coronary Heart Disease (Docket No 02P‐0505). Published: 14 July 2003. Last Modified: 09/07/2015. Available:
    1. U.S. Food and Drug Administration (FDA) . Guidance for Industry: A Food Labeling Guide (12. Appendix D: Qualified Health Claims). Qualified Health Claims: Letter of Enforcement Discretion ‐ Walnuts and Coronary Heart Disease (Docket No 02P‐0292). Published: 09 March 2004. Last Modified: 09/07/2015. Available:
    1. U.S. Food and Drug Administration (FDA) . Guidance for Industry: A Food Labeling Guide (12. Appendix D: Qualified Health Claims). Qualified Health Claim for Macadamia Nuts and Reduced Risk of Coronary Heart Disease (Docket No. FDA‐2015‐Q‐4850). Published: 09 March 2004. Last Modified: 09/07/2015. Available:
    1. International Nut & Dried Fruit Council (INC) . Nuts & Dried Fruits Statistical Yearbook 2018/2019. Available:
    1. American Heart Association . Go Nuts (But just a little!). Last Modified: June 25, 2015. Available:
    1. American Diabetes Association . Fats. Last Modified: August 13, 2015. Available:
    1. American Diabetes Association . On‐The‐Go Tips. Available:
    1. WebMD . Go Nuts on Your Diet ! 2003. Available:
    1. Health Canada , Government of Canada . Canadian Nutrient File (CNF), Nuts, pistachio nuts, raw. Last Modified: 2018‐02‐06. Available:
    1. Health Canada , Government of Canada . Canadian Nutrient File (CNF), Nuts, cashew nuts, raw. Last Modified: 2018‐02‐06. Available:
    1. Health Canada , Government of Canada . Canadian Nutrient File (CNF), Peanuts, all types, raw. Last Modified: 2018‐02‐06. Available:
    1. Health Canada , Government of Canada . Canadian Nutrient File (CNF), Nuts, almonds, dry roasted, unblanched. Last Modified: 2018‐02‐06. Available:
    1. Health Canada , Government of Canada . Canadian Nutrient File (CNF), Nuts, filberts or hazelnuts, dried. Last Modified: 2018‐02‐06. Available:
    1. Health Canada , Government of Canada . Canadian Nutrient File (CNF), Nuts, walnuts, English or Persian, dried. Last Modified: 2018‐02‐06. Available:
    1. Health Canada , Government of Canada . Canadian Nutrient File (CNF), Nuts, brazilnuts, dried, unblanched. Last Modified: 2018‐02‐06. Available:
    1. Health Canada , Government of Canada . Canadian Nutrient File (CNF), Nuts, pine nuts, pignolia, dried. Last Modified: 2018‐02‐06. Available:
    1. Health Canada , Government of Canada . Canadian Nutrient File (CNF), Nuts, pecans, dry roasted. Last Modified: 2018‐02‐06. Available:
    1. Health Canada , Government of Canada . Canadian Nutrient File (CNF), Nuts, macadamia (bushnuts, queensland), raw. Last Modified: 2018‐02‐06. Available:
    1. Eslami O, Shidfar F, Dehnad A. Inverse association of long‐term nut consumption with weight gain and risk of overweight/obesity: A systematic review. Nutrition research (New York, NY). 2019;68:1‐8.
    1. Flores‐Mateo G, Rojas‐Rueda D, Basora J, Ros E, Salas‐Salvado J. Nut intake and adiposity: Meta‐analysis of clinical trials. Am J Clin Nutr. 2013;97(6):1346‐1355.
    1. Guarneiri LL, Cooper JA. Intake of nuts or nut products does not lead to weight gain, independent of dietary substitution instructions: A systematic review and meta‐analysis of randomized trials. Adv Nutr (Bethesda, Md). 2020;12(2):384‐401.
    1. Higgins JPT, Thomas J, Chandler J, et al. (Eds). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane; 2019. Available from
    1. Stroup DF, Berlin JA, Morton SC, et al. Meta‐analysis of observational studies in epidemiology: a proposal for reporting. Meta‐analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008‐2012.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta‐analyses: The PRISMA statement. PLoS Med. 2009;6(7):e1000097.
    1. Source Forge . Plot Digitizer. Last Modified: 24 October 2015. Available:
    1. Wells G, Shea B, O'Connell D, et al. The Newcastle‐Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta‐Analyses. Ottawa Hospital Research Institute: Ottawa, ON, Canada; 2000.
    1. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clin Res ed). 2011;343:d5928.
    1. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Control Clin Trials. 1986;7(3):177‐188.
    1. Tufanaru C, Munn Z, Stephenson M, Aromataris E. Fixed or random effects meta‐analysis? Common methodological issues in systematic reviews of effectiveness. Int J Evid Based Healthc. 2015;13(3):196‐207.
    1. Bekkering GE, Harris RJ, Thomas S, et al. How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta‐analysis? Am J Epidemiol. 2008;167(9):1017‐1026.
    1. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clin Res ed). 1997;315:629‐634.
    1. Begg CB. A measure to aid in the interpretation of published clinical trials. Stat Med. 1985;4(1):1‐9.
    1. Duval S, Tweedie R. Trim and fill: A simple funnel‐plot‐based method of testing and adjusting for publication bias in meta‐analysis. Biometrics. 2000;56(2):455‐463.
    1. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383‐394.
    1. Bes‐Rastrollo M, Sabate J, Gomez‐Gracia E, Alonso A, Martinez JA, Martinez‐Gonzalez MA. Nut consumption and weight gain in a Mediterranean cohort: The SUN study. Obesity (Silver Spring, Md). 2007;15:107‐116.
    1. El‐Amari SS, Lloren JI, Sabate J. Nut intake, prospective weight change, and obesity risk: The adventist health study‐2. FASEB Journal Conference: Experimental Biology 2016; 30 417‐6
    1. Fernandez‐Montero A, Bes‐Rastrollo M, Beunza JJ, et al. Nut consumption and incidence of metabolic syndrome after 6‐year follow‐up: the SUN (Seguimiento Universidad de Navarra, University of Navarra Follow‐up) cohort. Public Health Nutr. 2013;16(11):2064‐2072.
    1. Freisling H, Noh H, Slimani N, et al. Nut intake and 5‐year changes in body weight and obesity risk in adults: results from the EPIC‐PANACEA study. Eur J Nutr. 2018;57(7):2399‐2408.
    1. Liu X, Li Y, Guasch‐Ferré M, Willett WC, et al. Changes in nut consumption influence long‐term weight change in US men and women. BMJ Nutr Prev Health. 2019;2(2):90‐99.
    1. Smith JD, Hou T, Hu FB, et al. A comparison of different methods for evaluating diet, physical activity, and long‐term weight gain in 3 prospective cohort studies. J Nutr. 2015;145(11):2527‐2534.
    1. Abazarfard Z, Salehi M, Keshavarzi S. The effect of almonds on anthropometric measurements and lipid profile in overweight and obese females in a weight reduction program: A randomized controlled clinical trial. J Res Med Sci. 2014;19(5):457‐464.
    1. Abbaspour N, Roberts T, Hooshmand S, Kern M, Hong MY. Mixed nut consumption may improve cardiovascular disease risk factors in overweight and obese adults. Nutrients. 2019;11(7):1488.
    1. Agebratt C, Strom E, Romu T, et al. A randomized study of the effects of additional fruit and nuts consumption on hepatic fat content, cardiovascular risk factors and basal metabolic rate. PLoS ONE. 2016;11:e0147149.
    1. Baer DJ, Novotny JA. Consumption of cashew nuts does not influence blood lipids or other markers of cardiovascular disease in humans: A randomized controlled trial. Am J Clin Nutr. 2019;109(2):269‐275.
    1. Balci MK, Balci B, Hoda P. Metabolic effects of walnuts in patients with prediabetic metabolic syndrome. Endocrine Reviews Conference: 94th Annual Meeting and Expo of the Endocrine Society, ENDO. 2012; 33.
    1. Barbour JA, Howe PR, Buckley JD, Bryan J, Coates AM. Effect of 12 weeks high oleic peanut consumption on cardio‐metabolic risk factors and body composition. Nutrients. 2015;7(9):7381‐7398.
    1. Bento AP, Cominetti C, Simoes Filho A, Naves MM. Baru almond improves lipid profile in mildly hypercholesterolemic subjects: A randomized, controlled, crossover study. Nutr Metab Cardiovasc Dis: NMCD. 2014;24(12):1330‐1336.
    1. Berryman CE, West SG, Fleming JA, Bordi PL, Kris‐Etherton PM. Effects of daily almond consumption on cardiometabolic risk and abdominal adiposity in healthy adults with elevated LDL‐cholesterol: A randomized controlled trial. J Am Heart Assoc. 2015;4:e000993.
    1. Bitok E, Rajaram S, Jaceldo‐Siegl K, et al. Effects of long‐term walnut supplementation on body weight in free‐living elderly: Results of a randomized controlled trial. Nutrients. 2018;10(9):1317.
    1. Duarte GBS, Reis BZ, Rogero MM, et al. Consumption of Brazil nuts with high selenium levels increased inflammation biomarkers in obese women: A randomized controlled trial. Nutrition (Burbank, Los Angeles County, Calif). 2019;63–64:162‐168.
    1. Bowen J, Luscombe‐Marsh ND, Stonehouse W, et al. Effects of almond consumption on metabolic function and liver fat in overweight and obese adults with elevated fasting blood glucose: A randomised controlled trial. Clin Nutr ESPEN. 2019;30:10‐18.
    1. Campbell A, Roychoudhury A, St‐Onge MP. Almond consumption increases satiety hormones relative to a high‐carbohydrate food but has minimal impact on body composition: A pilot study in black and hispanic adults. Circulation Conference: American Heart Association's Epidemiology and Prevention/Lifestyle and Cardiometabolic Health. 2019; 139.
    1. Canales A, Benedi J, Nus M, Librelotto J, Sanchez‐Montero JM, Sanchez‐Muniz FJ. Effect of walnut‐enriched restructured meat in the antioxidant status of overweight/obese senior subjects with at least one extra CHD‐risk factor. J Am Coll Nutr. 2007;26(3):225‐232.
    1. Carughi A, Bellisle F, Dougkas A, Giboreau A, Feeney MJ, Higgs J. A randomized controlled pilot study to assess effects of a daily pistachio (Pistacia Vera) afternoon snack on next‐meal energy intake, satiety, and anthropometry in french women. Nutrients. 2019;11(4):767.
    1. Casas‐Agustench P, Lopez‐Uriarte P, Bullo M, Ros E, Cabre‐Vila JJ, Salas‐Salvado J. Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis: NMCD. 2011;21(2):126‐135.
    1. Chisholm A, Mc Auley K, Mann J, Williams S, Skeaff M. Cholesterol lowering effects of nuts compared with a Canola oil enriched cereal of similar fat composition. Nutr Metab Cardiovasc Dis: NMCD. 2005;15(4):284‐292.
    1. Ciccone MMSP, Cortese F, Gesualdo M, et al. Endothelial function in ovese and overweight patients: The role of olive oil, fish and nuts. Int J Diabetes Clin Res. 2014;1:1‐5.
    1. Cohen AE, Johnston CS. Almond ingestion at mealtime reduces postprandial glycemia and chronic ingestion reduces hemoglobin A(1c) in individuals with well‐controlled type 2 diabetes mellitus. Metab: Clin Exp. 2011;60(9):1312‐1317.
    1. Damasceno NR, Perez‐Heras A, Serra M, et al. Crossover study of diets enriched with virgin olive oil, walnuts or almonds. Effects on lipids and other cardiovascular risk markers. Nutr Metab Cardiovasc Dis: NMCD. 2011;21(Suppl 1):S14‐S20.
    1. Damavandi RD, Eghtesadi S, Shidfar F, Heydari I, Foroushani AR. Effects of hazelnuts consumption on fasting blood sugar and lipoproteins in patients with type 2 diabetes. J Res Med Sci. 2013;18(4):314‐321.
    1. Damavandi RD, Shidfar F, Rajab A, Mohammadi V, Hosseini S. The effects of cashew consumption on serum glucose, insulin and lipoprotein in type 2 diabetic patients. Iran J Endocrinol Metab. 2012;14:Pe325‐Pe334. En413
    1. de Souza RGM, Gomes AC, de Castro IA, Mota JF. A baru almond‐enriched diet reduces abdominal adiposity and improves high‐density lipoprotein concentrations: A randomized, placebo‐controlled trial. Nutrition (Burbank, Los Angeles County, Calif). 2018;55–56:154‐160.
    1. Dhillon J, Tan SY, Mattes RD. Almond consumption during energy restriction lowers truncal fat and blood pressure in compliant overweight or obese adults. J Nutr. 2016;146(12):2513‐2519.
    1. Dhillon J, Thorwald M, De La Cruz N, et al. Glucoregulatory and cardiometabolic profiles of almond vs. cracker snacking for 8 weeks in young adults: A randomized controlled trial. Nutrients. 2018;10(8):960.
    1. Foster GD, Shantz KL, Vander Veur SS, et al. A randomized trial of the effects of an almond‐enriched, hypocaloric diet in the treatment of obesity. Am J Clin Nutr. 2012;96(2):249‐254.
    1. Gebauer SK, West SG, Kay CD, Alaupovic P, Bagshaw D, Kris‐Etherton PM. Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: A dose‐response study. Am J Clin Nutr. 2008;88(3):651‐659.
    1. Gulati S, Misra A, Pandey RM, Bhatt SP, Saluja S. Effects of pistachio nuts on body composition, metabolic, inflammatory and oxidative stress parameters in Asian Indians with metabolic syndrome: A 24‐wk, randomized control trial. Nutrition (Burbank, Los Angeles County, Calif). 2014;30:192‐197.
    1. Hernandez‐Alonso P, Salas‐Salvado J, Baldrich‐Mora M, Juanola‐Falgarona M, Bullo M. Beneficial effect of pistachio consumption on glucose metabolism, insulin resistance, inflammation, and related metabolic risk markers: A randomized clinical trial. Diabetes Care. 2014;37(11):3098‐3105.
    1. Hiraoka‐Yamamoto J, Ikeda K, Negishi H, et al. Serum lipid effects of a monounsaturated (palmitoleic) fatty acid‐rich diet based on macadamia nuts in healthy, young Japanese women. Clin Exp Pharmacol Physiol. 2004;31(Suppl 2):S37‐S38.
    1. Hollis J, Mattes R. Effect of chronic consumption of almonds on body weight in healthy humans. Br J Nutr. 2007;98(3):651‐656.
    1. Hudthagosol C, Haddad E, Jongsuwat R. Antioxidant activity comparison of walnuts and fatty fish. J Med Assoc Thai. 2012;95(Suppl 6):S179‐S188.
    1. Hwang HJ, Liu Y, Kim HS, Lee H, Lim Y, Park H. Daily walnut intake improves metabolic syndrome status and increases circulating adiponectin levels: Randomized controlled crossover trial. Nutr Res Pract. 2019;13(2):105‐114.
    1. Jamshed H, Sultan FA, Iqbal R, Gilani AH. Dietary almonds increase serum HDL cholesterol in coronary artery disease patients in a randomized controlled trial. J Nutr. 2015;145(10):2287‐2292.
    1. Jenkins DJ, Kendall CW, Marchie A, et al. Dose response of almonds on coronary heart disease risk factors: Blood lipids, oxidized low‐density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: A randomized, controlled, crossover trial. Circulation. 2002;106(11):1327‐1332.
    1. Jenkins DJA, Kendall CWC, Lamarche B, et al. Nuts as a replacement for carbohydrates in the diabetic diet: A reanalysis of a randomised controlled trial. Diabetologia. 2018;61(8):1734‐1747.
    1. Johnston CS, Trier CM, Fleming KR. The effect of peanut and grain bar preloads on postmeal satiety, glycemia, and weight loss in healthy individuals: An acute and a chronic randomized intervention trial. Nutr J. 2013;27:35.
    1. Jung H, Chen CO, Blumberg JB, Kwak HK. The effect of almonds on vitamin E status and cardiovascular risk factors in Korean adults: A randomized clinical trial. Eur J Nutr. 2018;57(6):2069‐2079.
    1. Katz DL, Davidhi A, Ma Y, Kavak Y, Bifulco L, Njike VY. Effects of walnuts on endothelial function in overweight adults with visceral obesity: A randomized, controlled, crossover trial. J Am Coll Nutr. 2012;31(6):415‐423.
    1. Kocyigit A, Koylu AA, Keles H. Effects of pistachio nuts consumption on plasma lipid profile and oxidative status in healthy volunteers. Nutr Metab Cardiovasc Dis: NMCD. 2006;16(3):202‐209.
    1. Le T, Flatt SW, Natarajan L, et al. Effects of diet composition and insulin resistance status on plasma lipid levels in a weight loss intervention in women. J Am Heart Assoc. 2016;5(1):e002771.
    1. Lee YJ, Nam GE, Seo JA, et al. Nut consumption has favorable effects on lipid profiles of Korean women with metabolic syndrome. Nutr Res (New York, NY). 2014;34:814‐820.
    1. Li SC, Liu YH, Liu JF, Chang WH, Chen CM, Chen CY. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metab: Clin Exp. 2011;60(4):474‐479.
    1. Li Z, Song R, Nguyen C, et al. Pistachio nuts reduce triglycerides and body weight by comparison to refined carbohydrate snack in obese subjects on a 12‐week weight loss program. J Am Coll Nutr. 2010;29(3):198‐203.
    1. Liu Y, Hwang HJ, Kim HS, Park H. Time and intervention effects of daily almond intake on the changes of lipid profile and body composition among free‐living healthy adults. J Med Food. 2018;21(4):340‐347.
    1. Ma Y, Njike VY, Millet J, et al. Effects of walnut consumption on endothelial function in type 2 diabetic subjects: A randomized controlled crossover trial. Diabetes Care. 2010;33(2):227‐232.
    1. McKay DL, Eliasziw M, Chen CYO, Blumberg JB. A Pecan‐Rich diet improves cardiometabolic risk factors in overweight and obese adults: A randomized controlled trial. Nutrients. 2018;10(3):339.
    1. Mohan V, Gayathri R, Jaacks LM, et al. Cashew nut consumption increases HDL cholesterol and reduces systolic blood pressure in Asian Indians with type 2 diabetes: A 12‐week randomized controlled trial. J Nutr. 2018;148(1):63‐69.
    1. Moreira Alves RD, Boroni Moreira AP, Macedo VS, et al. High‐oleic peanuts: New perspective to attenuate glucose homeostasis disruption and inflammation related obesity. Obesity (Silver Spring, Md). 2014;22:1981‐1988.
    1. Morgan JM, Horton K, Reese D, Carey C, Walker K, Capuzzi DM. Effects of walnut consumption as part of a low‐fat, low‐cholesterol diet on serum cardiovascular risk factors. Int J Vitam Nutr Res. 2002;72(5):341‐347.
    1. Morgan WA, Clayshulte BJ. Pecans lower low‐density lipoprotein cholesterol in people with normal lipid levels. J Am Diet Assoc. 2000;100(3):312‐318.
    1. Nagashree RS, Manjunath NK, Indu M, et al. Effect of a diet enriched with fresh coconut saturated fats on plasma lipids and erythrocyte fatty acid composition in normal adults. J Am Coll Nutr. 2017;36(5):330‐334.
    1. Njike VY, Ayettey R, Petraro P, Treu JA, Katz DL. Walnut ingestion in adults at risk for diabetes: Effects on body composition, diet quality, and cardiac risk measures. BMJ Open Diabetes Res Care. 2015;3(1):e000115.
    1. Njike VY, Kavak Y, Treu JA, Doughty K, Katz DL. snacking, satiety, and weight: A randomized, controlled trial. Am J Health Promot: AJHP. 2017;31(4):296‐301.
    1. Parham M, Heidari S, Khorramirad A, et al. Effects of pistachio nut supplementation on blood glucose in patients with type 2 diabetes: A randomized crossover trial. Rev Diabetic Stud: RDS. 2014;11(2):190‐196.
    1. Rajaram S, Burke K, Connell B, Myint T, Sabate J. A monounsaturated fatty acid‐rich pecan‐enriched diet favorably alters the serum lipid profile of healthy men and women. J Nutr. 2001;131(9):2275‐2279.
    1. Robbins WA, Xun L, FitzGerald LZ, Esguerra S, Henning SM, Carpenter CL. Walnuts improve semen quality in men consuming a Western‐style diet: randomized control dietary intervention trial. Biol Reprod. 2012;87(4):101.
    1. Rock CL, Flatt SW, Barkai HS, Pakiz B, Heath DD. Walnut consumption in a weight reduction intervention: Effects on body weight, biological measures, blood pressure and satiety. Nutr J. 2017;16(1):76.
    1. Ros E, Nunez I, Perez‐Heras A, et al. A walnut diet improves endothelial function in hypercholesterolemic subjects: A randomized crossover trial. Circulation. 2004;109(13):1609‐1614.
    1. Ruisinger JF, Gibson CA, Backes JM, et al. Statins and almonds to lower lipoproteins (the STALL Study). J Clin Lipidol. 2015;9(1):58‐64.
    1. Sabate J, Cordero‐Macintyre Z, Siapco G, Torabian S, Haddad E. Does regular walnut consumption lead to weight gain? Br J Nutr. 2005;94(5):859‐864.
    1. Sabate J, Haddad E, Tanzman JS, Jambazian P, Rajaram S. Serum lipid response to the graduated enrichment of a step I diet with almonds: A randomized feeding trial. Am J Clin Nutr. 2003;77(6):1379‐1384.
    1. Sauder KA, McCrea CE, Ulbrecht JS, Kris‐Etherton PM, West SG. Effects of pistachios on the lipid/lipoprotein profile, glycemic control, inflammation, and endothelial function in type 2 diabetes: A randomized trial. Metab: Clin Exp. 2015;64(11):1521‐1529.
    1. Schutte AE, Van Rooyen JM, Huisman HW, et al. Modulation of baroreflex sensitivity by walnuts versus cashew nuts in subjects with metabolic syndrome. Am J Hypertens. 2006;19(6):629‐636.
    1. Sheridan MJ, Cooper JN, Erario M, Cheifetz CE. Pistachio nut consumption and serum lipid levels. J Am Coll Nutr. 2007;26(2):141‐148.
    1. Somerset SM, Graham L, Markwell K. Isoenergetic replacement of dietary saturated with monounsaturated fat via macadamia nuts enhances endothelial function in overweight subjects. e‐SPEN J. 2013;8:e113‐e119.
    1. Spaccarotella KJ, Kris‐Etherton PM, Stone WL, et al. The effect of walnut intake on factors related to prostate and vascular health in older men. Nutr J. 2008;7(1):13.
    1. Spiller GA, Jenkins DA, Bosello O, Gates JE, Cragen LN, Bruce B. Nuts and plasma lipids: An almond‐based diet lowers LDL‐C while preserving HDL‐C. J Am Coll Nutr. 1998;17(3):285‐290.
    1. Sweazea KL, Johnston CS, Ricklefs KD, Petersen KN. Almond supplementation in the absence of dietary advice significantly reduces C‐reactive protein in subjects with type 2 diabetes. J Funct Foods. 2014;10:252‐259.
    1. Tan SY, Mattes RD. Appetitive, dietary and health effects of almonds consumed with meals or as snacks: A randomized, controlled trial. Eur J Clin Nutr. 2013;67(11):1205‐1214.
    1. Tapsell L, Batterham M, Tan SY, Warensjo E. The effect of a calorie controlled diet containing walnuts on substrate oxidation during 8‐hours in a room calorimeter. J Am Coll Nutr. 2009;28(5):611‐617.
    1. Tapsell LC, Gillen LJ, Patch CS, et al. Including walnuts in a low‐fat/modified‐fat diet improves HDL cholesterol‐to‐total cholesterol ratios in patients with type 2 diabetes. Diabetes Care. 2004;27(12):2777‐2783.
    1. Tapsell LC, Lonergan M, Batterham MJ, et al. Effect of interdisciplinary care on weight loss: A randomised controlled trial. BMJ Open. 2017;7(7):e014533.
    1. Tey SL, Brown R, Gray A, Chisholm A, Delahunty C. Nuts improve diet quality compared to other energy‐dense snacks while maintaining body weight. J Nutr Metab. 2011;2011:357350.
    1. Tey SL, Gray AR, Chisholm AW, Delahunty CM, Brown RC. The dose of hazelnuts influences acceptance and diet quality but not inflammatory markers and body composition in overweight and obese individuals. J Nutr. 2013;143(8):1254‐1262.
    1. Tindall AM, Petersen KS, Skulas‐Ray AC, Richter CK, Proctor DN, Kris‐Etherton PM. Replacing saturated fat with walnuts or vegetable oils improves central blood pressure and serum lipids in adults at risk for cardiovascular disease: A randomized controlled‐feeding trial. J Am Heart Assoc. 2019;8(9):e011512.
    1. Tsaban G, Wolak A, Avni‐Hassid H, et al. Dynamics of intrapericardial and extrapericardial fat tissues during long‐term, dietary‐induced, moderate weight loss. Am J Clin Nutr. 2017;106(4):984‐995.
    1. Vergani E, Bruno C, Olivieri G, et al. Differential metabolic response to various regimens of natural antioxidant enriched‐diets in patients with insulin resistance. Endocrine Reviews Conference: 100th Annual Meeting of the Endocrine Society, ENDO. 2018; 39.
    1. Wang X, Li Z, Liu Y, Lv X, Yang W. Effects of pistachios on body weight in Chinese subjects with metabolic syndrome. Nutr J. 2012;11(1):20.
    1. Wien M, Bleich D, Raghuwanshi M, et al. Almond consumption and cardiovascular risk factors in adults with prediabetes. J Am Coll Nutr. 2010;29(3):189‐197.
    1. Wien M, Oda K, Sabate J. A randomized controlled trial to evaluate the effect of incorporating peanuts into an American Diabetes Association meal plan on the nutrient profile of the total diet and cardiometabolic parameters of adults with type 2 diabetes. Nutr J. 2014;13(1):10.
    1. Wien MA, Sabate JM, Ikle DN, Cole SE, Kandeel FR. Almonds vs complex carbohydrates in a weight reduction program. Int J Obes Relat Metab Disord. 2003;27(11):1365‐1372.
    1. Williams PT, Bergeron N, Chiu S, Krauss RM. A randomized, controlled trial on the effects of almonds on lipoprotein response to a higher carbohydrate, lower fat diet in men and women with abdominal adiposity. Lipids Health Dis. 2019;18(1):83.
    1. Wilson TYJ, Anderson AD, Anderson MM, et al. Effect of bedtime pistachio consumption for 6 weeks on weight, lipid profile and glycemic status in overweight persons. Int J Food Sci Nutr. 2014;1(1):1‐4.
    1. Wu H, Pan A, Yu Z, et al. Lifestyle counseling and supplementation with flaxseed or walnuts influence the management of metabolic syndrome. J Nutr. 2010;140(11):1937‐1942.
    1. Zambon D, Sabate J, Munoz S, et al. Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial. Ann Intern Med. 2000;132(7):538‐546.
    1. Bamberger C, Rossmeier A, Lechner K, et al. A Walnut‐enriched diet reduces lipids in healthy caucasian subjects, independent of recommended macronutrient replacement and time point of consumption: A prospective, randomized, controlled trial. Nutrients. 2017;9(10):1097.
    1. Biude Silva Duarte G, Zavarize Reis B, Cercato C, Macedo Rogero M, Maria Franciscato Cozzolino S. Brazilian nut intake has no influence on body composition in obese women. Ann Nutr Metab. 2017;71(Supplement 2):1142.
    1. Estruch R, Martinez‐Gonzalez MA, Corella D, et al. Effect of a high‐fat Mediterranean diet on bodyweight and waist circumference: A prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7(5):e6‐e17.
    1. Shah RV, Murthy VL, Allison MA, et al. Diet and adipose tissue distributions: The multi‐ethnic study of atherosclerosis. Nutr Metab Cardiovasc Dis: NMCD. 2016;26(3):185‐193.
    1. Paniagua JA, Gallego de la Sacristana A, Romero I, et al. Monounsaturated fat‐rich diet prevents central body fat distribution and decreases postprandial adiponectin expression induced by a carbohydrate‐rich diet in insulin‐resistant subjects. Diabetes Care. 2007;30(7):1717‐1723.
    1. Piers LS, Walker KZ, Stoney RM, Soares MJ, O'Dea K. The influence of the type of dietary fat on postprandial fat oxidation rates: Monounsaturated (olive oil) vs saturated fat (cream). Int J Obes Relat Metab Disord. 2002;26(6):814‐821.
    1. Casas‐Agustench P, Lopez‐Uriarte P, Bullo M, Ros E, Gomez‐Flores A, Salas‐Salvado J. Acute effects of three high‐fat meals with different fat saturations on energy expenditure, substrate oxidation and satiety. Clin Nutr. 2009;28(1):39‐45.
    1. Weigle DS, Breen PA, Matthys CC, et al. A high‐protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am J Clin Nutr. 2005;82(1):41‐48.
    1. Jaceldo‐Siegl K, Sabate J, Rajaram S, Fraser GE. Long‐term almond supplementation without advice on food replacement induces favourable nutrient modifications to the habitual diets of free‐living individuals. Br J Nutr. 2004;92(3):533‐540.
    1. Rebello CJ, Liu AG, Greenway FL, Dhurandhar NV. Dietary strategies to increase satiety. Adv Food Nutr Res. 2013;69:105‐182.
    1. Mattes RD, Dreher ML. Nuts and healthy body weight maintenance mechanisms. Asia Pac J Clin Nutr. 2010;19(1):137‐141.
    1. Ellis PR, Grundy M, Grassby T, et al. The role of dietary fiber in regulating lipid bioaccessibility of almonds during mastication. FASEB Journal. 2012;26(S1):1015.4.
    1. Ellis PR, Kendall CW, Ren Y, et al. Role of cell walls in the bioaccessibility of lipids in almond seeds. Am J Clin Nutr. 2004;80(3):604‐613.
    1. Cassady BA, Hollis JH, Fulford AD, Considine RV, Mattes RD. Mastication of almonds: Effects of lipid bioaccessibility, appetite, and hormone response. Am J Clin Nutr. 2009;89(3):794‐800.
    1. Nishi SK, Kendall CWC, Bazinet RP, et al. almond bioaccessibility in a randomized crossover trial: Is a calorie a calorie? Mayo Clinic proceedings. 2021.
    1. Gebauer SK, Novotny JA, Bornhorst GM, Baer DJ. Food processing and structure impact the metabolizable energy of almonds. Food Funct. 2016;7(10):4231‐4238.
    1. Baer DJ, Gebauer SK, Novotny JA. Walnuts consumed by healthy adults provide less available energy than predicted by the atwater factors. J Nutr. 2016;146(1):9‐13.
    1. Baer DJ, Novotny JA. metabolizable energy from cashew nuts is less than that predicted by atwater factors. Nutrients. 2018;11(1):33.
    1. World Health Organization (WHO) . Obestiy and overweight. Last Modified: 03 March 2020. Available:

Source: PubMed

3
Se inscrever